Nonpharmacological Intervention Effects on Middle-Aged Women with Menopausal Symptoms: A Systematic Review and

Ji-Hyun Kim1, Hea-Jin Yu1

  • 1College of Nursing, Sahmyook University, 815 Hwarang-ro, Nowon-gu, Seoul 01795, Republic of Korea.

PubMed

Background: Middle-aged women frequently experience diverse physical and psychological symptoms, including depression, anxiety, sleep disturbances, vasomotor symptoms, and reduced quality of life, during menopause. With increasing concerns regarding the side effects of hormone therapy, nonpharmacological interventions have emerged as safer alternatives for symptom management. Purpose: This systematic review and meta-analysis evaluated the effectiveness of nonpharmacological interventions for menopausal symptoms in middle-aged women. Methods: Thirty-two randomized controlled trials were selected from eight international and domestic databases. Interventions were categorized as nutritional or herbal, psychological, exercise-based, and complementary therapies. Risk of bias was assessed using the Cochrane risk of bias tool, and meta-analyses were performed using a random effects model. Results: Nonpharmacological interventions significantly reduced symptoms of depression (standardized mean difference (SMD) = -1.10), anxiety (-0.82), sleep disturbances (-0.90), menopausal symptoms (-1.18), and hot flashes (-0.34). Improvement in quality of life was observed, but it was not statistically significant (SMD = 1.40). Subgroup analyses revealed that nutritional and herbal interventions had the most consistent effects, and psychological and exercise-based interventions were particularly effective for improving sleep outcomes and emotional well-being. Conclusions: Nonpharmacological interventions effectively improve menopausal symptoms and quality of life, with tailored and multifaceted approaches showing the greatest impact. Nurse-led, community-based programs are key delivery platforms, and sustainable outcomes require standardized protocols, cultural responsiveness, and ongoing evaluation.

Related Concept Videos

Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.4K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
174